Autori: Ciuleanu Tudor E
| Naslov | Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe (Article) |
| Autori | Zemanova Milada Jakopovic Marko Stanic Karmen Lazar-Poniatowska Malgorzata Vrankar Martina Rusu Petronela Ciuleanu Tudor E Radosavljevic Davorin Z Bogos Krisztina Nawrocki Sergiusz |
| Info | RADIOLOGY AND ONCOLOGY, (2020), vol. 54 br. 4, str. 447-454 |
| Projekat | AstraZeneca |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) (Article) |
| Autori | Pillai Rathi N Fennell Dean A Kovcin Vladimir N Ciuleanu Tudor E Ramlau Rodryg Kowalski Dariusz Schenker Michael Yalcin Ilker Teofilovici Florentina Vukovic Vojo M Ramalingam Suresh S |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 6, str. 613-+ |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis (Article) |
| Autori | Cufer Tanja Ciuleanu Tudor E Berzinec Peter Galffy Gabriela Jakopovic Marko Jassem Jacek Jovanovic Dragana D Mihaylova Zhasmina Ostoros Gyula Thallinger Christiane Zemanova Milada Zielinski Christoph |
| Info | ONCOLOGIST, (2020), vol. 25 br. 3, str. E598-E601 |
| Projekat | AstraZeneca |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) (Meeting Abstract) |
| Autori | Pillai Rathi N Fennell Dean Kovcin Vladimir N Ciuleanu Tudor E Ramlau Rodryg Kowalski Dariusz Schenker Michael Perin Branislav M Yalcin Ilker Teofilovici Florentina Vukovic Vojo M Ramalingam Suresh S |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2017), vol. 12 br. 1, Suppl. S, str. S7-S8 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article) |
| Autori | Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777 |
| Projekat | CECOG |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank Magdolna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Cetuximab Weekly (Q1W) Versus Every Two Weeks (Q2W) Plus Folfox4 as First-line Therapy in Patients (PTS) with Kras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Kahan Zsuzsanna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2011), vol. 22 br. , Suppl. Suppl. 5, str. v22-v22 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy. (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Samarzjia M Demidchik Y Beliakouski V Rancic M Bentsion DL Orlov SV Schaeffier BA De Jager RL Breitz HB |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2010), vol. 28 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
